PIP2
Athanor · official
C47H85O19P3 · 1047.1 g/mol
IUPAC name: [(2R)-1-[hydroxy-[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-diphosphonooxycyclohexyl]oxyphosphoryl]oxy-3-octadecanoyloxypropan-2-yl] (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
Also called phosphatidylinositol-4,5-bisphosphate, PtdIns(4,5)P2, PI(4,5)P2, second messenger precursor
Names and identifiers
- IUPAC name
- [(2R)-1-[hydroxy-[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-diphosphonooxycyclohexyl]oxyphosphoryl]oxy-3-octadecanoyloxypropan-2-yl] (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate
- Synonyms
- phosphatidylinositol-4,5-bisphosphate, PtdIns(4,5)P2, PI(4,5)P2
+ 25 more
second messenger precursor, Brain PI(4,5)P2, L-alpha-Phosphatidylinositol-4,5-bisphosphate, [(2R)-1-[hydroxy-[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-diphosphonooxycyclohexyl]oxyphosphoryl]oxy-3-octadecanoyloxypropan-2-yl] (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate, (2R)-1-[(hydroxy{[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxy}phosphoryl)oxy]-3-(octadecanoyloxy)propan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate, 1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol 4,5-biphosphate, orb1983439, SCHEMBL25241360, CHEBI:77276, DTXSID10420578, BP182690, DA-66681, L-?-phosphatidylinositol-4,5-bisphosphate, HY-114457, CS-0085953, T73812, 1-stearoyl-2-arachidonoyl-sn-phosphatidylinositol 4,5-biphosphate, 1-Stearoyl-2-arachidonoyl-sn-glycero-3-phosphoinositol-4,5-bisphosphate, [(2R)-1-[hydroxy-[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-diphosphonooxycyclohexyl]oxyphosphoryl]oxy-3-octadecanoyloxypropan-2-yl](5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate, 1-octadecanoyl-2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-3-phospho-1D-myo-inositol 4,5-biphosphate, 1-octadecanoyl-2-(5Z,8Z,11Z,14Z)-icosatetraenoyl-sn-glycero-3-phospho-1D-myo-inositol 4,5-biphosphate, 5,8,11,14-eicosatetraenoic acid, (1R)-2-[[hydroxy[[(1R,2R,3S,4R,5R,6S)-2,3,6-trihydroxy-4,5-bis(phosphonooxy)cyclohexyl]oxy]phosphinyl]oxy]-1-[[(1-oxooctadecyl)oxy]methyl]ethyl ester, (5Z,8Z,11Z,14Z)-, D-Myo-inositol, 4,5-bis(dihydrogen phosphate) 1-((2R)-2-(((5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-eicosatetraen-1-yl)oxy)-3-((1-oxooctadecyl)oxy)propyl hydrogen phosphate), D-Myo-inositol, 4,5-bis(dihydrogen phosphate) 1-((2R)-2-(((5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-eicosatetraenyl)oxy)-3-((1-oxooctadecyl)oxy)propyl hydrogen phosphate), D-myo-Inositol, 4,5-bis(dihydrogen phosphate) 1-[(2R)-2-[[(5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-eicosatetraenyl]oxy]-3-[(1-oxooctadecyl)oxy]propyl hydrogen phosphate] (9CI)
- Molecular formula
- C47H85O19P3
- Empirical formula
- C47H85O19P3
- Molecular weight
- 1047.1 g/mol
- Exact mass
- 1046.48979
- CAS number
- 245126-95-8
- PubChem CID
- 5497157
- Canonical SMILES
- CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OC1C(C(C(C(C1O)OP(=O)(O)O)OP(=O)(O)O)O)O)OC(=O)CCCC=CCC=CCC=CCC=CCCCCC
- Isomeric SMILES
- CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[C@@H]1[C@@H]([C@@H]([C@H]([C@@H]([C@H]1O)OP(=O)(O)O)OP(=O)(O)O)O)O)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC
- InChI
- InChI=1S/C47H85O19P3/c1-3-5-7-9-11-13-15-17-19-20-22-24-26-28-30-32-34-36-41(49)63-39(37-61-40(48)35-33-31-29-27-25-23-21-18-16-14-12-10-8-6-4-2)38-62-69(59,60)66-45-42(50)43(51)46(64-67(53,54)55)47(44(45)52)65-68(56,57)58/h11,13,17,19,22,24,28,30,39,42-47,50-52H,3-10,12,14-16,18,20-21,23,25-27,29,31-38H2,1-2H3,(H,59,60)(H2,53,54,55)(H2,56,57,58)/b13-11-,19-17-,24-22-,30-28-/t39-,42-,43+,44+,45-,46-,47-/m1/s1
- InChIKey
- CNWINRVXAYPOMW-FCNJXWMTSA-N
- Molfile
Names, InChI and the identifiers from PubChem, retrieved 2026-10-14.
Calculated
- Heavy atoms
- 69
- Rings
- 1
- Aromatic rings
- 0
- Fraction sp³ carbons (Fsp3)
- 0.79
- H-bond donors
- 8
- H-bond acceptors
- 14 computed here · PubChem 19
- Rotatable bonds
- 42 computed here · PubChem 44
- TPSA (Ų)
- 302.6 computed here · PubChem 303
- Formal charge
- 0
- XLogP3
- 8.3 PubChem
- Complexity
- 1630 PubChem
- Stereocenters
- 7 defined, 1 undefinedCIP: C22: R · P25: undefined · C29: R · C30: R · C32: S · C34: R · C40: R · C46: S
- Double-bond geometry
- C54=C55: Z · C57=C58: Z · C60=C61: Z · C63=C64: Z
Elemental analysis
- C53.91%
- H8.18%
- O29.03%
- P8.87%
Isotope pattern
Each peak is a nominal mass with its abundance-weighted exact mass, as a percentage of the tallest, from IUPAC natural isotope abundances.
Computed from the structure with RDKit 2026.09 when this page was built, beside PubChem's own computed values from its record; where the two differ, both are shown.
Predicted
- log P
- 9.4 Crippen (Wildman and Crippen 1999)
- log S (water solubility)
- -9.48 ESOL (Delaney 2004), log mol/L
- Synthetic accessibility
- 5.49 SA score, 1 easy to 10 hard (Ertl and Schuffenhauer 2009)
Drug-likeness: Lipinski’s rule of five
- Molecular weight ≤ 500: 1047.1
- log P ≤ 5 (Crippen): 9.4
- H-bond donors ≤ 5: 8
- H-bond acceptors ≤ 10: 14
Breaks 4 of the four rules.
¹³C NMR shifts, predicted
Predictions, not measurements; each names its method. A measured log P, where a source reports one, is under Physical properties.
Safety
No GHS hazard classification was found in the sources.
Safety data sheets on the supplier’s page: TargetMol, LGC Standards, Debye Scientific Co., Ltd.
Always read the supplier’s safety data sheet before working with it.
Literature
Reading PubChem, OpenAlex and GSRS…
Bioactivity
Reading ChEMBL…
References
- ·Calculated values: computed by Athanor with RDKit 2026.09 from the structure.
- ·Literature on PubChem
Data last updated 2026-10-14.
